Offer - Urjas Oil for just ₹ 1
Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet is a prescription medicine that is available as a Tablet. Secondary and off-label uses of Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet have also been mentioned below.
The right dosage of Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Common side effects of Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet include Back Pain, Loss of appetite, Gastric Irritation. Besides the aforementioned side effects, there are other adverse effects of Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet as well, which are listed below. Usually, these side effects of Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet's effect during pregnancy is Mild and Mild while nursing. It is important to know if Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet related warnings section.
Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Low Blood Pressure (Hypotension), Angioedema, Hyperkalemia are examples of such conditions. Some other conditions that can be affected by Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet are listed in the contraindications section below.
Drug interactions for Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet is considered not safe while driving, and is not addictive.
Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet safe for pregnant women?
Telmipack Trio has mild to no side effects in pregnant women.
Is the use of Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet safe during breastfeeding?
Telmipack Trio may have very limited harmful effects for breastfeeding women.
What is the effect of Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet on the Kidneys?
Telmipack Trio rarely affects the kidneys.
What is the effect of Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet on the Liver?
Telmipack Trio has very mild side effects on the liver.
What is the effect of Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet on the Heart?
Telmipack Trio may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet unless your doctor advises you to do so -
Is this Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet habit forming or addictive?
No, there is no any evidence that Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet is addictive.
Interaction between Food and Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet
When consumed with certain foods, Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet
Consult your doctor before consuming alcohol while taking Telmipack Trio 40 Mg/10 Mg/6.25 Mg Tablet as it can have severe side effects.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
